Brands and Their Owners
Welcome to the Brand page for “IFORMULATE”, which is offered here for I formulate;pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using design of experiments approach in a multivariate fashion; pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using design of experiments approach in a multivariate fashion; pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using design of experiments approach in a multivariate fashion; pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (adcs), all the foregoing using design of experiments approach in a multivariate fashion; pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of ph, ionic strength, buffer and stability concentrations, all the foregoing using design of experiments approach in a multivariate fashion;scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced design of experiments strategy; scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced design of experiments strategy;.
Its status is currently believed to be active. Its class is unavailable. “IFORMULATE” is believed to be currently owned by “HTD Biosystems, Inc.”
Owner: |
HTD BIOSYSTEMS, INC.
Owner Details |
---|---|
Description: |
I FORMULATE;Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion;Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy;
|
Categories: | FORMULATE |